Recovery & RepairARA-290
10MG
$100
Description
ARA-290 (Cibinetide) is an 11-amino-acid peptide derived from erythropoietin (EPO) that selectively activates the innate repair receptor (IRR), a heteromer of the EPO receptor and the beta common receptor. Unlike EPO itself, ARA-290 does not stimulate red blood cell production or increase hematocrit, making it a targeted tissue-protective and anti-inflammatory compound without the cardiovascular risks associated with EPO. ARA-290 promotes tissue repair, reduces inflammation, and has shown remarkable potential in neuropathic pain research. It works by activating anti-inflammatory pathways while simultaneously promoting the survival and function of cells under metabolic stress.
Potential Benefits
Research Notes
Clinical trials published in Molecular Medicine demonstrated ARA-290 significantly reduced neuropathic pain symptoms in patients with sarcoidosis and type 2 diabetes. Research in the Journal of Translational Medicine showed it promotes corneal nerve fiber regeneration and improves small nerve fiber density. Phase II clinical data confirmed its favorable safety profile with no erythropoietic activity. ARA-290 represents a novel approach to tissue repair by leveraging the protective properties of EPO signaling without its blood-stimulating effects.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.